<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Surgical treatment of primary and secondary lymphedema</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Surgical treatment of primary and secondary lymphedema</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Surgical treatment of primary and secondary lymphedema</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Babak Mehrara, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Amy S Colwell, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Collins, MD, PhD, FACS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 08, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H186726226"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Operative management of primary and secondary lymphedema is typically reserved for localized primary malformations, failed medical management, or recurrent cellulitis in affected extremities. There is no consensus regarding the role of surgery, the optimal surgical approach, or the timing of an operative procedure for extremity lymphedema.</p><p>The indications, preoperative evaluation, and operative management of primary and secondary lymphedema will be reviewed here. Other characteristics of lymphedema, including etiology, diagnosis, and clinical manifestations, are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/755.html" rel="external">"Clinical features and diagnosis of peripheral lymphedema"</a> and  <a class="medical medical_review" href="/d/html/738.html" rel="external">"Clinical staging and conservative management of peripheral lymphedema"</a> and  <a class="medical medical_review" href="/d/html/6096.html" rel="external">"Pathophysiology and etiology of edema in children"</a> and  <a class="medical medical_review" href="/d/html/6878.html" rel="external">"Clinical manifestations and evaluation of edema in adults"</a>.)</p><p class="headingAnchor" id="H186726305"><span class="h1">INDICATIONS FOR SURGERY</span><span class="headingEndMark"> — </span>Nonoperative measures, including compressive garments and decongestive therapy, are the initial approach for management of lymphedema, as discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/738.html" rel="external">"Clinical staging and conservative management of peripheral lymphedema", section on 'Overview of management'</a>.) </p><p>The indications for operative management of primary and secondary lymphedema include [<a href="#rid1">1-6</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Localized primary lesions (including microcystic and macroscopic lymphatic malformations)</p><p class="bulletIndent1"><span class="glyph">●</span>Failed nonoperative management</p><p class="bulletIndent1"><span class="glyph">●</span>Recurrent cellulitis</p><p class="bulletIndent1"><span class="glyph">●</span>Leakage of lymph into body cavities, organs, or externally</p><p class="bulletIndent1"><span class="glyph">●</span>Limitation of function</p><p class="bulletIndent1"><span class="glyph">●</span>Deformity or disfigurement</p><p class="bulletIndent1"><span class="glyph">●</span>Pain or other severe symptoms such as heaviness or tightness</p><p class="bulletIndent1"><span class="glyph">●</span>Diminished quality of life, including emotional and psychosocial distress</p><p></p><p>The goals of surgical management of lymphedema are to alleviate pain and discomfort, retain or restore function, reduce the risk of infection, prevent disease progression, improve cosmesis, and limit deformity [<a href="#rid7">7-18</a>].</p><p>There is no consensus on the timing of surgery or optimal surgical intervention [<a href="#rid7">7,19</a>]. The decision to perform an operative procedure to treat lymphedema should be made on a case-by-case basis. </p><p class="headingAnchor" id="H186730238"><span class="h1">PREOPERATIVE EVALUATION</span><span class="headingEndMark"> — </span>The preoperative evaluation should include confirmation that the etiology of the lymphedema is due to a congenital or obstructive lymphatic process and not to edema related to a chronic condition, such as heart failure, venous obstruction, or protein deficiency. Chronic edema is managed medically by treating the underlying disease. (See  <a class="medical medical_review" href="/d/html/755.html" rel="external">"Clinical features and diagnosis of peripheral lymphedema", section on 'Diagnosis'</a>.)</p><p>The following preoperative assessments are performed:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assess the degree of lymphedema</strong> – The circumference, or preferably the volume, of the affected extremity is compared with the unaffected limb to document the degree of lymphedema. Measurements are taken at fixed intervals at specific anatomic sites (eg, ankle, mid-calf, knee, mid-thigh for lower extremity measurements), although there may be significant interexaminer variability with this approach [<a href="#rid20">20</a>]. Multiple measurements along the extremity can also be used to calculate limb volumes using the truncated cone formula [<a href="#rid21">21</a>]. Volumetric measurement using water displacement is the most accurate assessment tool but is cumbersome to perform and provides variable results when compression garments are used or there are changes in patient activity, and hence is rarely used [<a href="#rid22">22</a>]. Perometry (optoelectronic), a technique that utilizes infrared light, can estimate cross-sectional measurements at multiple intervals and convert this information into limb volume metrics [<a href="#rid23">23</a>]. The degree of lymphedema at other sites is performed by measuring the affected area. In our practice, we measure limb circumference at two points: above and below a major joint in addition to perometry. For example, in assessing upper extremity lymphedema, the circumference is measured 10 cm above and 5 cm below the olecranon on both the affected and unaffected limb.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lymphedema stage</strong> – The staging system of the International Society of Lymphology (ISL) is the most commonly used system for staging of lymphedema  (<a class="graphic graphic_table graphicRef122830" href="/d/graphic/122830.html" rel="external">table 1</a>) [<a href="#rid24">24</a>]. (See  <a class="medical medical_review" href="/d/html/738.html" rel="external">"Clinical staging and conservative management of peripheral lymphedema"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Venous duplex ultrasound or MR imaging/MR angiogram</strong> – For patients who will undergo a physiologic procedure, ultrasound or an magnetic resonance (MR) imaging/MR angiogram is performed to rule out venous thrombosis, venous insufficiency, and/or valvular incompetence [<a href="#rid25">25,26</a>]. </p><p></p><p class="headingAnchor" id="H186726312"><span class="h1">OPERATIVE MANAGEMENT</span><span class="headingEndMark"> — </span>Operative management of lymphedema is categorized into two general approaches: physiologic techniques and reductive techniques. In some cases, physiologic procedures, such as lymph node transplantation or lymphovenous bypass, can be combined with reductive procedures such as liposuction to maximize results.</p><p class="bulletIndent1"><span class="glyph">●</span>Physiologic treatments consist of either lymph node transplantation wherein healthy lymph nodes are harvested from a donor area and microsurgically transplanted to the lymphedematous limb (arterial and venous circulation are reattached) or lymphovenous bypass in which a lymphatic vessel is drained into the venous circulation distal to the area of lymphatic obstruction. Physiologic procedures are used for patients with early-stage lymphedema prior to the deposition of excess fat and extensive tissue fibrosis (ie, International Society of Lymphology [ISL] stage I or II)  (<a class="graphic graphic_table graphicRef122830" href="/d/graphic/122830.html" rel="external">table 1</a>). (See <a class="local">'Physiologic techniques'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reductive techniques for lymphedema aim to remove the deposited fibrofatty tissue. These procedures are performed using either liposuction with small cannulas inserted into the subcutaneous space or, less commonly, by radical resection of the excess tissues. Reductive techniques are best used in patients who have failed conservative measures or for patients who present with more advanced lymphedema after fat deposition and tissue fibrosis has occurred (ie, ISL stage II or III  (<a class="graphic graphic_table graphicRef122830" href="/d/graphic/122830.html" rel="external">table 1</a>)). (See <a class="local">'Reductive techniques'</a> below.)</p><p></p><p class="headingAnchor" id="H186726319"><span class="h2">Physiologic techniques</span><span class="headingEndMark"> — </span>Physiologic techniques create new channels to increase the capacity of the lymphatic system to transport lymph fluid [<a href="#rid27">27</a>]. The fluids trapped in lymphedematous tissues are drained into other lymphatic basins or into the venous circulation. In general, surgical intervention is feasible as long as tissue changes in the affected limb (eg, fibrosis, fat hypertrophy) are not severe. Patients with more advanced lymphedema have been treated with physiologic techniques; however, the results are variable, and only limited numbers of patients have been analyzed [<a href="#rid18">18,19,28-30</a>]. </p><p>The surgical approaches to accomplish this goal include lymphatic bypass procedures, flap transposition procedures, and vascularized lymph node transfers. The lymphatic bypass procedures are more commonly used of the physiologic techniques. These procedures require a high level of technical skill, and performance of these procedures should be reserved for those surgeons who have expertise in microvascular surgery. </p><p>Because secondary lymphedema results in functional impairment and poor cosmesis, attempts have been made to prevent lymphedema by using physiologic procedures at the time of a lymphadenectomy [<a href="#rid25">25,27,31-36</a>]. A prospective trial included 46 patients with breast cancer undergoing an axillary lymphadenectomy with or without a lymphaticovenous anastomosis (lymphatic vessels anastomosed to branches of the axillary vein) performed at the same operative setting. Patients treated with a lymphaticovenous anastomosis (lymphatic vessels anastomosed to branches of the axillary vein) had a lower risk of lymphedema compared with patients without the procedure at 18 months of follow-up (4 versus 30 percent) [<a href="#rid34">34</a>]. The definition of lymphedema was 100 mL volume displacement in this trial, whereas others used 200 mL as the definition of lymphedema. This discrepancy in the definition of lymphedema should be standardized for ease in evaluating various treatment and preventive approaches. Improvements in patient symptoms and volumetric changes are also supported by meta-analyses [<a href="#rid30">30,37</a>].</p><p class="headingAnchor" id="H4258367"><span class="h3">Lymphatic bypass procedures</span><span class="headingEndMark"> — </span>Lymphatic bypass procedures are used in the following settings:</p><p class="bulletIndent1"><span class="glyph">●</span>Failure of nonoperative management (see  <a class="medical medical_review" href="/d/html/738.html" rel="external">"Clinical staging and conservative management of peripheral lymphedema", section on 'Overview of management'</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Recurrent cellulitis or lymphangitis</p><p class="bulletIndent1"><span class="glyph">●</span>Dissatisfaction with compression garments or impaired quality of life</p><p></p><p>Relative contraindications to lymphatic bypass procedures include:</p><p class="bulletIndent1"><span class="glyph">●</span>Extensive tissue fibrosis </p><p class="bulletIndent1"><span class="glyph">●</span>Late-stage lymphedema changes </p><p class="bulletIndent1"><span class="glyph">●</span>Venous hypertension</p><p class="bulletIndent1"><span class="glyph">●</span>Recurrent cancer in the ipsilateral extremity or metastatic disease</p><p class="bulletIndent1"><span class="glyph">●</span>Patient noncompliance with compression therapy or postoperative care plans</p><p class="bulletIndent1"><span class="glyph">●</span>Body mass index &gt;35</p><p class="bulletIndent1"><span class="glyph">●</span>Active smoking</p><p></p><p>Primary or secondary forms of lymphedema can be treated with this approach, although the efficacy of these procedures in primary lymphedema has been debated [<a href="#rid4">4,7,38,39</a>]. </p><p>The basic principle is that lymphatic vessels distal to the lymphatic obstruction are anastomosed to a nearby vein such that lymphatic fluid is shunted to the venous system and bypasses the area of lymphatic obstruction. As an example, when the lymphatics are transected at the level of the axilla, a bypass is created by connecting the distal lymphatic vessels in the upper arm to a nearby venule. </p><p class="headingAnchor" id="H4258819"><span class="h4">Methods</span><span class="headingEndMark"> — </span>There are several methods used to perform a bypass procedure. There is no consensus for the specific type of lymphatic bypass procedure to be performed; these decisions are made based on surgeon preference and experience. To help identify the lymphatic vessels, prior to making an incision, <a class="drug drug_general" data-topicid="9039" href="/d/drug information/9039.html" rel="external">isosulfan blue dye</a> or other dyes such as <a class="drug drug_general" data-topicid="8461" href="/d/drug information/8461.html" rel="external">fluorescein</a> or <a class="drug drug_general" data-topicid="8982" href="/d/drug information/8982.html" rel="external">indocyanine green</a> are injected into the subdermal tissues distal to the operative site [<a href="#rid27">27</a>]. </p><p class="headingAnchor" id="H1146246321"><span class="h5">Lymphaticovenous anastomosis</span><span class="headingEndMark"> — </span>This is a super-microsurgical technique used to anastomose distal subdermal lymphatic vessels and adjacent venules less than 0.8 mm in diameter [<a href="#rid27">27,38,40</a>]. Distal subdermal lymphatics are less affected by lymphedema and are more readily available for a bypass procedure than deeper lymphatic channels. The pressure in the subdermal venules is lower than found in the deeper, larger veins. Hence, there is less venous backflow in the subdermal vessels, and, at least in theory, this should result in a permanent improvement of lymphedema. </p><p class="headingAnchor" id="H1213471819"><span class="h5">Vascularized lymph node transplant</span><span class="headingEndMark"> — </span>Lymph node transplantation is a procedure that includes the transplantation of healthy lymph nodes en bloc from one nodal basin to the site of obstruction [<a href="#rid41">41-43</a>]. The recipient site can be the site of the prior lymph node excision or a nonanatomic site. Some authors have suggested that a "lymphatic pump" is created when lymph nodes are transferred nonanatomically; however, the mechanisms regulating lymphatic repair in this setting remain unknown [<a href="#rid15">15,42</a>]. The nodes are transplanted using microsurgical techniques with arterial and venous anastomosis at the recipient site; there is usually no lymphatic anastomosis with this approach. A limiting factor of this approach is that lymphedema can develop in the donor extremity. This possibility has led to the use of mesenteric lymph nodes (eg, omentum [<a href="#rid44">44</a>], intestinal mesentery lymph nodes) as an alternative since harvesting lymph nodes from these areas does not result in lymphedema. These issues have to be balanced, however, with potential complications from intra-abdominal procedures (eg, hernia, small bowel obstruction, pancreatic injury). Prospective studies from tertiary cancer centers have shown that these procedures are effective in most carefully selected procedures [<a href="#rid28">28,29</a>].This concept is also supported by systematic reviews that support a beneficial role (ie, decreased limb volume and improved quality of life) for this procedure in the majority of patients [<a href="#rid28">28,30,37,45,46</a>].</p><p class="headingAnchor" id="H4258521"><span class="h4">Outcomes</span><span class="headingEndMark"> — </span>Most of the outcome data for physiologic techniques are from retrospective reviews of mostly lymphatic bypass procedures [<a href="#rid47">47</a>]. Prospective studies have also been reported [<a href="#rid28">28,48</a>]. </p><p>Lymphatic bypass procedures result in highly variable responses, ranging from a complete response to none. The variability of results among the different studies is likely due to a number of factors including differences in assessing volume or circumference, length of follow-up, variable use of postoperative compression garments and/or physical therapy, and the use of nonstandardized or nonvalidated questionnaires for subjective analysis. There has been no standardization of assessing volume of lymphedematous limb, and numerous techniques are reported to approximate volume changes following an operative procedure. Few studies report the use of complimentary techniques (eg, volume measurements and bioimpedance or lymphoscintigraphy) to corroborate measurements. However, these limitations have been addressed in later studies [<a href="#rid48">48</a>]. Other caveats include mixed series of patients, either based upon etiology (eg, primary congenital conditions, or secondary lymphedema following nodal resections, trauma, or filariasis); location of lymphedema (eg, upper or lower extremity); and/or variable criteria for patient selection, selection of procedures, timing of intervention, and identification of suitable lymphatic vessels for bypass surgery. </p><p>In spite of these limitations, most authors report improvements in limb volumes (30 to 50 percent decreased), although a few individual patients experienced marked reductions, particularly for the upper extremity [<a href="#rid18">18,26,27,38-40,49,50</a>]. In a study in which lymphovenous bypass was performed in 89 upper extremities and 11 lower extremities, the mean volume differential reductions were significantly better for stage I or II lymphedema compared with stage III or IV lymphedema (61 versus 17 percent at six months) [<a href="#rid49">49</a>]. In a prospective study of 100 consecutive patients undergoing lymphovenous bypass, 96 percent of patients with upper extremity lymphedema had symptomatic improvement (lighter, softer, less painful arms), and 74 percent had quantitative reduction in excess volume [<a href="#rid49">49</a>]. Progression of lymphedema postoperatively is uncommon [<a href="#rid18">18,38,39</a>]. Long-term studies (follow-up &gt;3 years) have shown improvements with bypass procedures are maintained even when the use of a compression garment is discontinued [<a href="#rid26">26,38,40</a>]. A systematic review identified 24 studies evaluating the outcomes of lymphovenous microsurgery [<a href="#rid51">51</a>]. The majority of patients (91.2 percent) reported a subjective improvement. At follow-up, 65 percent of patients discontinued compression garments. Outcomes stratified by type of procedure and anatomic location are given below: </p><p class="bulletIndent1"><span class="glyph">●</span>Excess percent circumference reduction</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>All – 48.8 percent (95% CI 42.8-54.8) (11 studies; 131 patients) </p><p class="bulletIndent2"><span class="glyph">•</span>Upper extremity – 46.0 percent (95% CI 39.0-53.0) (7 studies; 90 patients)</p><p class="bulletIndent2"><span class="glyph">•</span>Lower extremity – 57.4 percent (95% CI 44.5-70.3) (4 studies; 34 patients) </p><p class="bulletIndent2"><span class="glyph">•</span>Lymphovenous shunt – 48.9 percent (95% CI 40.7-57.2) (7 studies; 80 patients)</p><p class="bulletIndent2"><span class="glyph">•</span>Lymph node transfer – 48.5 percent (95% CI 35.3-61.6) (4 studies; 51 patients)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Absolute circumference reduction</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>All – 3.31 centimeters (95% CI 2.58-4.04) (11 studies; 138 patients)</p><p class="bulletIndent2"><span class="glyph">•</span>Upper extremity – 2.73 centimeters (95% CI 1.63-3.83) (6 studies; 79 patients)</p><p class="bulletIndent2"><span class="glyph">•</span>Lower extremity – 3.52 centimeters (95% CI 2.28-4.75) (5 studies; 52 patients)</p><p></p><p>A large retrospective review not included in the above systematic review included approximately 1800 patients undergoing a microsurgical lymphatic-venous bypass procedure [<a href="#rid26">26</a>]. Subjective improvement was reported in 87 percent, objective improvement in 83 percent, and the mean volume reduction was 67 percent. The incidence of cellulitis was decreased by 87 percent following lymphatic bypass procedures. Several other case reports and small series suggest that lymphatic bypass procedures may also be effective in reducing primary and secondary genital lymphedema [<a href="#rid26">26,38,39,52,53</a>]. Prospective studies are required to evaluate the efficacy of lymphatic bypass procedures in this setting.</p><p>Three large prospective studies have reported outcomes following vascularized lymph node transfer (VLNT) alone or in combination with lymphovenous bypass (LVB) [<a href="#rid28">28,29,48</a>]. A study of 134 patients who underwent VLNT or VLNT and simultaneous LVB for primary and secondary lymphedema reported significant reductions in limb volume and L-Dex score [<a href="#rid28">28</a>]. The authors reported that 97.1 percent of patients had decreased L-Dex scores, 90.2 percent had decreased limb volume, and 96.2 percent had an improved quality-of-life score using a validated lymphedema questionnaire. When analyzed one and two years postop, this study reported a reduction of 34.7 and 45.7 percent in limb volume, respectively. Similar improvements were noted for L-Dex measurements and quality-of-life outcomes. Another study with 89 patients reported an 85 percent reduction in the rates of recurrent infections in patients treated with vascularized lymph node transplantation [<a href="#rid29">29</a>].</p><p>A study of 274 patients who underwent VLNT with or without LVB or LVB alone reported similar outcomes [<a href="#rid48">48</a>]. In this study, nearly 90 percent of patients with upper extremity lymphedema and 60 percent of patients with lower extremity lymphedema had decreased limb volume after surgery. At one and two years after surgery, upper limb volume decreased by 25.7 and 47.4 percent, respectively. Approximately 86 percent of patients with upper extremity lymphedema also had improvements in quality-of-life outcomes as measured by a validated questionnaire. Outcomes for lower extremity lymphedema were also excellent, though less impressive than those noted in patients with upper extremity lymphedema.</p><p>The rate of complications following lymphatic bypass procedures is low [<a href="#rid7">7,27,32,38</a>]. Most complications are minor, such as delayed wound healing and lymphatic fistula, and typically improve spontaneously. Postoperative cellulitis is uncommon, most likely due to long-term postoperative antibiotic therapy [<a href="#rid32">32,38</a>]. In the systematic review, surgical site infection occurred in 4.7 percent, lymph leak in 7.7 percent, reexploration was needed for flap congestion in 2.7 percent, and other procedures were performed in 22.6 percent [<a href="#rid51">51</a>]. </p><p class="headingAnchor" id="H186726382"><span class="h2">Reductive techniques</span><span class="headingEndMark"> — </span>Reductive techniques (also called ablative techniques) remove fibrofatty tissue that has been generated from sustained lymphatic fluid stasis. The reductive procedures are designed to reduce bulk due to lymphedema and are palliative, not curative, for patients with secondary lymphedema  (<a class="graphic graphic_figure graphicRef104429" href="/d/graphic/104429.html" rel="external">figure 1</a>), but can be curative in patients with localized primary lymphatic malformations. This category of procedures includes direct excision and liposuction. The goals of these techniques are the same as the physiologic techniques: alleviate pain, restore function, reduce swelling, and limit deformity. There are no randomized trials to determine the optimal procedure to treat lymphedema. </p><p class="headingAnchor" id="H186726389"><span class="h3">Direct excision</span><span class="headingEndMark"> — </span>A variety of direct excision procedures have been described for the treatment of extremity and genital lymphedema [<a href="#rid14">14,25,34,54-60</a>]. Lymphedematous tissues are excised en bloc, including the skin and soft tissues. The resulting defects are covered either with tissue flaps (Homans, Sistrunk, Thompson procedures) or with skin grafts (Charles procedure). </p><p>Radical excision of skin and subcutaneous tissues is generally reserved for patients with very severe disease who have failed all other measures. These procedures are particularly useful in areas where liposuction is not possible (eg, scrotal lymphedema). These procedures are much more invasive than liposuction and may result in substantial morbidity. Nevertheless, severe symptoms in some patients justify this approach [<a href="#rid61">61</a>]. </p><p class="headingAnchor" id="H186726396"><span class="h3">Liposuction</span><span class="headingEndMark"> — </span>Liposuction is highly effective in the upper extremity. While liposuction has also been reported in a more limited number of patients, the technique also appears to be effective for treatment of lower extremity lymphedema [<a href="#rid62">62-68</a>]. This procedure is relatively simple to perform and has low rates of complications, such as minor infections and paresthesias. Patients treated in this manner may have substantial (&gt;90 percent) long-term decrease in limb volume and improved quality of life if compression garments are worn at all times [<a href="#rid69">69,70</a>]. However, liposuction does not cure the underlying disorder, and noncompliance with the use of compression garments results in reaccumulation of fibrofatty tissues, usually within three to six months. </p><p>Lymphedema of the upper arm following breast cancer surgery is associated with a 73 percent increase in adipose tissue by volumetrics; hence, liposuction is an alternative procedure for treating upper extremity lymphedema [<a href="#rid62">62,71</a>]. Liposuction should be used in conjunction with compression garments [<a href="#rid63">63,72-75</a>] and physiologic techniques [<a href="#rid76">76</a>] to treat lymphedema of the upper extremities. </p><p>The indications for liposuction for the treatment of upper extremity lymphedema include [<a href="#rid73">73,77</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Nonpitting edema that has failed nonoperative management for greater than three months</p><p class="bulletIndent1"><span class="glyph">●</span>Localized fat deposits</p><p class="bulletIndent1"><span class="glyph">●</span>Symptomatic complaints including heaviness, shoulder and/or neck strain or pain</p><p class="bulletIndent1"><span class="glyph">●</span>Functional impairments</p><p class="bulletIndent1"><span class="glyph">●</span>Recurrent infections </p><p></p><p>The contraindications for liposuction for the treatment of upper-extremity lymphedema include:</p><p class="bulletIndent1"><span class="glyph">●</span>Lymphangiosarcoma of the affected arm</p><p class="bulletIndent1"><span class="glyph">●</span>Open wounds in the lymphedematous arm</p><p class="bulletIndent1"><span class="glyph">●</span>Active smoking</p><p></p><p class="headingAnchor" id="H447662757"><span class="h3">Outcomes for reductive techniques</span><span class="headingEndMark"> — </span>Most of the outcome data for reductive techniques are from retrospective reviews and small case series and case reports. Liposuction can also be combined with physiologic techniques [<a href="#rid78">78,79</a>].</p><p class="headingAnchor" id="H663078349"><span class="h4">Direct excision outcomes</span><span class="headingEndMark"> — </span>Procedures that involve direct excision of lymphedematous tissues are invasive and may result in pain, wound healing complications, infections, lymphatic fistulas, and a suboptimal cosmetic result [<a href="#rid14">14</a>]. Severe wound healing complications may, in some cases, even worsen lymphedema necessitating amputation [<a href="#rid80">80</a>]. The range and rate of complications is not well reported.</p><p>The effectiveness of operative management of lymphedema by reductive techniques varies with location and extensiveness of the involved tissues.</p><p><strong>Primary lymphedema of extremities and genitalia</strong> – Postoperative complications following surgical excision and reconstruction of the extremities include infection, necrosis of the skin graft, poor cosmesis and poor functional results, and foot edema [<a href="#rid14">14</a>]. Complications following surgical excision of lymphedematous tissue and reconstruction of the genitalia include hemorrhage, urethral injury, infection, painful erection, sexual dysfunction, decreased sensation, and scar in suture line [<a href="#rid81">81,82</a>]. </p><p>The largest single-institution observational study of excision and reconstructive procedures to reduce the bulk of lymphedematous extremity and genital tissue illustrates the effectiveness of this procedure [<a href="#rid10">10</a>]. Quality of life was assessed using the SF-36 questionnaire.</p><p>For patients with primary lymphedema of the extremities:</p><p class="bulletIndent1"><span class="glyph">●</span>In the retrospective component of this study, 78 patients had undergone 174 procedures, and 63 percent (49 patients) noted a decrease in limb size. Of these 49 patients, 71 percent would have opted again for the surgery while only 17 percent (5 of 29 with no improvement) would opt for an attempt at a surgical reduction again. Overall, quality of life improved for 23 patients and physical activity improved for 26.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The prospective component included 10 patients; nine reported a decrease in limb size. Seven of the 10 patients would opt for the reconstructive procedure again. Quality of life improved in seven patients and physical activity improved for four.</p><p></p><p>For patients with primary lymphedema of the genitalia:</p><p class="bulletIndent1"><span class="glyph">●</span>In the retrospective review of 13 patients (12 male and 1 female) undergoing 32 excision and reconstructive procedures, the overall results were mixed. Quality of life was improved in eight patients, sexual function improved in five, physical activity improved in seven, and 11 stated they would still opt for the surgical attempt to reduce lymphedema. All patients did have a reduction in the size of the genitalia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The prospective review included eight patients, all with reduction in size of the genitalia. Quality of life was improved for seven patients, physical activity was improved for six, sexual function was improved for four, and all eight patients would opt again for surgical excision and reconstruction.</p><p></p><p>The perception that the operative procedure was worthwhile for reduction of lymphedematous tissue of the extremities and/or genitalia was significantly higher in the patients evaluated prospectively compared with patients evaluated retrospectively (83 versus 56 percent). The difference in perception may be secondary to poor recall or a deteriorating quality of life with time. Quality of life was significantly improved for patients undergoing genitalia reduction compared with those undergoing surgery for lymphedematous extremities (71 versus 34 percent).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Long-term results of extremity lymphedema </strong>– A retrospective review of 38 patients with lower extremity lymphedema (primary or secondary) treated by skin and subcutaneous excision found long-lasting decrease in lymphedema and improved function and contour in 30 patients [<a href="#rid57">57</a>]. The average length of follow-up was 14 years (range 3 to 17 years). Five patients had progression of lymphedema following the procedure, and the sixth patient had progression of lymphedema associated with weight gain.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Localized lesions </strong>– The recurrence rate after macroscopically resecting a localized lesion ranges from 15 to 40 percent [<a href="#rid83">83</a>]. Recurrence is hypothesized to result from a regrowth and re-expansion of microscopic, unresected lymphatic channels. Cutaneous vesicles may occur within the surgical scar and can be managed with additional surgical resections and/or sclerotherapy.</p><p></p><p class="headingAnchor" id="H663078356"><span class="h4">Liposuction outcomes</span><span class="headingEndMark"> — </span>In general, circumferential liposuction for lymphedema is safe with few reported postoperative complications. When complications do occur, they tend to be minor and include occasional paresthesias and minor wound healing issues. The use of tourniquets and tumescent technique significantly decreases blood loss, and patients rarely require transfusions. Liposuction alone provides only temporary and palliative relief of symptoms for mild cases of lymphedema [<a href="#rid66">66</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cadaver and imaging studies</strong> – Cadaver and imaging studies have demonstrated that liposuction does not disrupt lymphatic vessels (if performed parallel to the limb) and that treatment of lymphedema with liposuction does<strong> </strong>not decrease the already impaired lymphatic transport capacity of the limb [<a href="#rid63">63,73,74,84-86</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Upper extremity</strong> – The following prospective studies illustrate the results of liposuction for patients with upper arm lymphedema following an axillary dissection for breast cancer:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A review of 37 patients with unilateral nonpitting stage II lymphedema treated with conservative management for two to four days followed by circumferential suction-assisted liposuction and continued use of compression therapy found the mean reduction in upper arm volumes was 118 percent 12 months after the procedure [<a href="#rid75">75</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A prospective case matched study (n = 28) found that patients treated with liposuction with continued use of controlled compression therapy had significantly decreased lymphedema compared with patients undergoing controlled compression therapy alone after one year (mean difference = 1000 mL) [<a href="#rid72">72</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Liposuction combined with physiologic techniques (myocutaneous flap transfer and lymph fascia grafting) in 11 patients with severe lymphedema of the upper extremity resulted in an approximate 10 percent decrease in lymphedema after three years [<a href="#rid76">76</a>]. The mean number of episodes of cellulitis decreased after the surgical procedure compared with preoperative episodes (0.7 versus 6.5 episodes per year).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lower extremity</strong> – Evidence for efficacy of liposuction for lower extremity lymphedema is less convincing and comprised primarily of case reports and small series [<a href="#rid52">52,59,60,63-66,80</a>]. The initial reports showed only minor improvements with lower extremity liposuction [<a href="#rid66">66,80</a>]. Small series and case studies have found improved cosmetic and functional results with advanced liposuction devices [<a href="#rid8">8,60,65,72,87</a>]. </p><p></p><p class="headingAnchor" id="H186730246"><span class="h1">POSTOPERATIVE MANAGEMENT</span><span class="headingEndMark"> — </span>Patients are admitted for one to five days after surgery for postoperative pain management and wound care [<a href="#rid18">18,26,27</a>]. The limbs are elevated for 24 hours for more limited procedures and up to one week for more extensive procedures [<a href="#rid26">26,27,63</a>]. </p><p>Compression garments are worn postoperatively to prevent the recurrence of lymphedema following physiologic and reductive procedures [<a href="#rid63">63</a>]. The garment fit is reassessed every four to six months to ensure that adequate compression is maintained. There is no consensus on the start time, length of time to continue wearing garments, or even the type of garment [<a href="#rid7">7,26,27,40</a>]. Typically, however, compression garments are started one week after surgery and used for 6 to 12 months. Most patients continue to wear garments indefinitely, although in some cases these may be discontinued with close follow-up [<a href="#rid26">26</a>]. The use of postoperative compression garments is critical for maintenance of volume reductions in the upper extremity after liposuction. Fluid reaccumulation occurred rapidly without postoperative compression therapy [<a href="#rid72">72</a>]. Compression garments are adjusted as necessary to maintain a tight fit. Data assessing the effectiveness of upper extremity liposuction are based upon small series of patients [<a href="#rid72">72-74</a>].</p><p>Antibiotics are typically used for one week postoperatively; however, prolonged use of prophylactic antibiotics may extend from four weeks to one year [<a href="#rid7">7,18,26</a>]. The skin is managed with water-based, gentle moisturizing creams to prevent skin drying or cracking.</p><p class="headingAnchor" id="H2651312401"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/120754.html" rel="external">"Society guideline links: Lymphedema"</a>.)</p><p class="headingAnchor" id="H186726425"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lymphedema</strong> <strong>surgery</strong> – Management of primary and secondary lymphedema is typically nonsurgical. However, advances in surgical techniques have shown significant promise for many patients with this disease. The decision to perform an operative procedure to treat lymphedema should be made on a case-by-case basis. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications for surgery</strong> – Operative management of lymphedema using physiologic procedures is effective for most patients with stage I, II, and even in some cases stage III lymphedema  (<a class="graphic graphic_table graphicRef122830" href="/d/graphic/122830.html" rel="external">table 1</a>). The majority of carefully selected patients who undergo physiologic reconstruction experience decreased limb volume and improved quality of life. Outcomes in the upper extremity tend to be better than those of the lower extremity. Patients with late-stage disease may benefit from reductive procedures or a combination of reductive and physiologic procedures. (See <a class="local">'Indications for surgery'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Preoperative evaluation</strong> – The preoperative evaluation should include confirmation of etiology of the lymphedema (eg, congenital process or obstructive process versus chronic condition such as heart disease), limb measurements or volumetric assessment to determine degree of lymphedema, and in select cases, venous duplex ultrasound or MR imaging/MR angiogram to assess for valvular competency and/or thrombosis. (See <a class="local">'Preoperative evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physiologic techniques</strong> – The physiologic procedures create new channels to increase the capacity of the lymphatic system to transport lymph fluid. The basic principle is that the lymphatic vessels distal to the lymphatic obstruction are anastomosed to healthy lymphatic vessels or veins proximal to the obstruction. (See <a class="local">'Physiologic techniques'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reductive techniques</strong> – Reductive techniques (also called ablative techniques) remove fibrofatty tissue that has been generated from sustained lymphatic fluid stasis. (See <a class="local">'Reductive techniques'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Operative management</strong> – Physiologic procedures are used for patients with lymphedema prior to development of extensive tissue fibrosis (eg, International Society of Lymphology [ISL] stage I, II, or early stage III)  (<a class="graphic graphic_table graphicRef122830" href="/d/graphic/122830.html" rel="external">table 1</a>). We use reductive techniques when patients present with more advanced lymphedema after fat deposition and tissue fibrosis has occurred (eg, late-stage ISL II or ISL III). (See <a class="local">'Operative management'</a> above.) </p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Ahmed RL, Prizment A, Lazovich D, et al. Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study. J Clin Oncol 2008; 26:5689.</a></li><li><a class="nounderline abstract_t">Pyszel A, Malyszczak K, Pyszel K, et al. Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema. Lymphology 2006; 39:185.</a></li><li><a class="nounderline abstract_t">Franks PJ, Moffatt CJ, Doherty DC, et al. Assessment of health-related quality of life in patients with lymphedema of the lower limb. Wound Repair Regen 2006; 14:110.</a></li><li><a class="nounderline abstract_t">Beaulac SM, McNair LA, Scott TE, et al. Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg 2002; 137:1253.</a></li><li><a class="nounderline abstract_t">Brady MS, Garfein CF, Petrek JA, Brennan MF. Post-treatment sarcoma in breast cancer patients. Ann Surg Oncol 1994; 1:66.</a></li><li class="breakAll">Smithers CJ, Fishman SJ. Chapter 74: Vascular anomalies.  Lymphatic malformations. In: Ashcraft's Pediatric Surgery, 5th ed, Holcomb GW III, Murphy JP, Ostlie DJ (Eds), Saunders Elsevier, Philadelphia 2010. p.989.</li><li><a class="nounderline abstract_t">Demirtas Y, Ozturk N, Yapici O, Topalan M. Comparison of primary and secondary lower-extremity lymphedema treated with supermicrosurgical lymphaticovenous anastomosis and lymphaticovenous implantation. J Reconstr Microsurg 2010; 26:137.</a></li><li><a class="nounderline abstract_t">Espinosa-de-Los-Monteros A, Hinojosa CA, Abarca L, Iglesias M. Compression therapy and liposuction of lower legs for bilateral hereditary primary lymphedema praecox. J Vasc Surg 2009; 49:222.</a></li><li><a class="nounderline abstract_t">van der Walt JC, Perks TJ, Zeeman BJ, et al. Modified Charles procedure using negative pressure dressings for primary lymphedema: a functional assessment. Ann Plast Surg 2009; 62:669.</a></li><li><a class="nounderline abstract_t">Ogunbiyi SO, Modarai B, Smith A, et al. Quality of life after surgical reduction for severe primary lymphoedema of the limbs and genitalia. Br J Surg 2009; 96:1274.</a></li><li><a class="nounderline abstract_t">Kitsiou-Tzeli S, Vrettou C, Leze E, et al. Milroy's primary congenital lymphedema in a male infant and review of the literature. In Vivo 2010; 24:309.</a></li><li><a class="nounderline abstract_t">Lee B, Andrade M, Bergan J, et al. Diagnosis and treatment of primary lymphedema. Consensus document of the International Union of Phlebology (IUP)-2009. Int Angiol 2010; 29:454.</a></li><li><a class="nounderline abstract_t">Symvoulakis EK, Anyfantakis DI, Lionis C. Primary lower limb lymphedema: a focus on its functional, social and emotional impact. Int J Med Sci 2010; 7:353.</a></li><li><a class="nounderline abstract_t">Tiwari A, Cheng KS, Button M, et al. Differential diagnosis, investigation, and current treatment of lower limb lymphedema. Arch Surg 2003; 138:152.</a></li><li><a class="nounderline abstract_t">Suami H, Chang DW. Overview of surgical treatments for breast cancer-related lymphedema. Plast Reconstr Surg 2010; 126:1853.</a></li><li><a class="nounderline abstract_t">Brennan MJ, Miller LT. Overview of treatment options and review of the current role and use of compression garments, intermittent pumps, and exercise in the management of lymphedema. Cancer 1998; 83:2821.</a></li><li><a class="nounderline abstract_t">Oztunç F, Koca B, Adaletli I. Generalised lymphangiomatosis in an 8-year-old girl who presented with cardiomegaly. Cardiol Young 2011; 21:465.</a></li><li><a class="nounderline abstract_t">Damstra RJ, Voesten HG, van Schelven WD, van der Lei B. Lymphatic venous anastomosis (LVA) for treatment of secondary arm lymphedema. A prospective study of 11 LVA procedures in 10 patients with breast cancer related lymphedema and a critical review of the literature. Breast Cancer Res Treat 2009; 113:199.</a></li><li><a class="nounderline abstract_t">Campisi C, Davini D, Bellini C, et al. Lymphatic microsurgery for the treatment of lymphedema. Microsurgery 2006; 26:65.</a></li><li><a class="nounderline abstract_t">Taylor R, Jayasinghe UW, Koelmeyer L, et al. Reliability and validity of arm volume measurements for assessment of lymphedema. Phys Ther 2006; 86:205.</a></li><li><a class="nounderline abstract_t">Brorson H, Höijer P. Standardised measurements used to order compression garments can be used to calculate arm volumes to evaluate lymphoedema treatment. J Plast Surg Hand Surg 2012; 46:410.</a></li><li><a class="nounderline abstract_t">Sander AP, Hajer NM, Hemenway K, Miller AC. Upper-extremity volume measurements in women with lymphedema: a comparison of measurements obtained via water displacement with geometrically determined volume. Phys Ther 2002; 82:1201.</a></li><li><a class="nounderline abstract_t">Stanton AW, Northfield JW, Holroyd B, et al. Validation of an optoelectronic limb volumeter (Perometer). Lymphology 1997; 30:77.</a></li><li><a class="nounderline abstract_t">International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema. 2009 Concensus Document of the International Society of Lymphology. Lymphology 2009; 42:51.</a></li><li><a class="nounderline abstract_t">Boccardo FM, Ansaldi F, Bellini C, et al. Prospective evaluation of a prevention protocol for lymphedema following surgery for breast cancer. Lymphology 2009; 42:1.</a></li><li><a class="nounderline abstract_t">Campisi C, Bellini C, Campisi C, et al. Microsurgery for lymphedema: clinical research and long-term results. Microsurgery 2010; 30:256.</a></li><li><a class="nounderline abstract_t">Chang DW. Lymphaticovenular bypass for lymphedema management in breast cancer patients: a prospective study. Plast Reconstr Surg 2010; 126:752.</a></li><li><a class="nounderline abstract_t">Schaverien MV, Asaad M, Selber JC, et al. Outcomes of Vascularized Lymph Node Transplantation for Treatment of Lymphedema. J Am Coll Surg 2021; 232:982.</a></li><li><a class="nounderline abstract_t">Brown S, Mehrara BJ, Coriddi M, et al. A Prospective Study on the Safety and Efficacy of Vascularized Lymph Node Transplant. Ann Surg 2022; 276:635.</a></li><li><a class="nounderline abstract_t">Chang DW, Dayan J, Greene AK, et al. Surgical Treatment of Lymphedema: A Systematic Review and Meta-Analysis of Controlled Trials. Results of a Consensus Conference. Plast Reconstr Surg 2021; 147:975.</a></li><li><a class="nounderline abstract_t">Campisi C, Boccardo F. Lymphedema and microsurgery. Microsurgery 2002; 22:74.</a></li><li><a class="nounderline abstract_t">Demirtas Y, Ozturk N, Yapici O, Topalan M. Supermicrosurgical lymphaticovenular anastomosis and lymphaticovenous implantation for treatment of unilateral lower extremity lymphedema. Microsurgery 2009; 29:609.</a></li><li><a class="nounderline abstract_t">Boccardo F, Casabona F, De Cian F, et al. Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol 2009; 16:703.</a></li><li><a class="nounderline abstract_t">Boccardo FM, Casabona F, Friedman D, et al. Surgical prevention of arm lymphedema after breast cancer treatment. Ann Surg Oncol 2011; 18:2500.</a></li><li><a class="nounderline abstract_t">Johnson AR, Fleishman A, Granoff MD, et al. Evaluating the Impact of Immediate Lymphatic Reconstruction for the Surgical Prevention of Lymphedema. Plast Reconstr Surg 2021; 147:373e.</a></li><li><a class="nounderline abstract_t">Johnson AR, Asban A, Granoff MD, et al. Is Immediate Lymphatic Reconstruction Cost-effective? Ann Surg 2021; 274:e581.</a></li><li><a class="nounderline abstract_t">Chun MJ, Saeg F, Miller D, et al. Surgical Lymphedema Treatment: A Meta-Analysis and Recommendations. Eplasty 2022; 22:e51.</a></li><li><a class="nounderline abstract_t">O'Brien BM, Mellow CG, Khazanchi RK, et al. Long-term results after microlymphaticovenous anastomoses for the treatment of obstructive lymphedema. Plast Reconstr Surg 1990; 85:562.</a></li><li><a class="nounderline abstract_t">Gloviczki P, Fisher J, Hollier LH, et al. Microsurgical lymphovenous anastomosis for treatment of lymphedema: a critical review. J Vasc Surg 1988; 7:647.</a></li><li><a class="nounderline abstract_t">Koshima I, Inagawa K, Urushibara K, Moriguchi T. Supermicrosurgical lymphaticovenular anastomosis for the treatment of lymphedema in the upper extremities. J Reconstr Microsurg 2000; 16:437.</a></li><li><a class="nounderline abstract_t">Dionyssiou D, Demiri E, Tsimponis A, et al. A randomized control study of treating secondary stage II breast cancer-related lymphoedema with free lymph node transfer. Breast Cancer Res Treat 2016; 156:73.</a></li><li><a class="nounderline abstract_t">Lin CH, Ali R, Chen SC, et al. Vascularized groin lymph node transfer using the wrist as a recipient site for management of postmastectomy upper extremity lymphedema. Plast Reconstr Surg 2009; 123:1265.</a></li><li><a class="nounderline abstract_t">Becker C, Assouad J, Riquet M, Hidden G. Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation. Ann Surg 2006; 243:313.</a></li><li><a class="nounderline abstract_t">Kenworthy EO, Nelson JA, Verma R, et al. Double vascularized omentum lymphatic transplant (VOLT) for the treatment of lymphedema. J Surg Oncol 2018; 117:1413.</a></li><li><a class="nounderline abstract_t">Ozturk CN, Ozturk C, Glasgow M, et al. Free vascularized lymph node transfer for treatment of lymphedema: A systematic evidence based review. J Plast Reconstr Aesthet Surg 2016; 69:1234.</a></li><li><a class="nounderline abstract_t">Nguyen AT, Suami H, Hanasono MM, et al. Long-term outcomes of the minimally invasive free vascularized omental lymphatic flap for the treatment of lymphedema. J Surg Oncol 2017; 115:84.</a></li><li><a class="nounderline abstract_t">Bissig I, Brunisholz RA, Suter F, et al. The complete amino acid sequences of the B800-850 antenna polypeptides from Rhodopseudomonas acidophila strain 7750. Z Naturforsch C J Biosci 1988; 43:77.</a></li><li><a class="nounderline abstract_t">Beederman M, Garza RM, Agarwal S, Chang DW. Outcomes for Physiologic Microsurgical Treatment of Secondary Lymphedema Involving the Extremity. Ann Surg 2022; 276:e255.</a></li><li><a class="nounderline abstract_t">Chang DW, Suami H, Skoracki R. A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema. Plast Reconstr Surg 2013; 132:1305.</a></li><li><a class="nounderline abstract_t">Yamamoto Y, Horiuchi K, Sasaki S, et al. Follow-up study of upper limb lymphedema patients treated by microsurgical lymphaticovenous implantation (MLVI) combined with compression therapy. Microsurgery 2003; 23:21.</a></li><li><a class="nounderline abstract_t">Basta MN, Gao LL, Wu LC. Operative treatment of peripheral lymphedema: a systematic meta-analysis of the efficacy and safety of lymphovenous microsurgery and tissue transplantation. Plast Reconstr Surg 2014; 133:905.</a></li><li><a class="nounderline abstract_t">Chitale VR. Role of tensor fascia lata musculocutaneous flap in lymphedema of the lower extremity and external genitalia. Ann Plast Surg 1989; 23:297.</a></li><li><a class="nounderline abstract_t">Mukenge SM, Catena M, Negrini D, et al. Assessment and follow-up of patency after lymphovenous microsurgery for treatment of secondary lymphedema in external male genital organs. Eur Urol 2011; 60:1114.</a></li><li><a class="nounderline abstract_t">Servelle M. Surgical treatment of lymphedema: a report on 652 cases. Surgery 1987; 101:485.</a></li><li class="breakAll">Charles R. Elephantiasis scroti, Churchill, London 1912.</li><li><a class="nounderline abstract_t">Kinmonth JB, Patrick JH, Chilvers AS. Comments on operations for lower limb lymphoedema. Lymphology 1975; 8:56.</a></li><li><a class="nounderline abstract_t">Miller TA, Wyatt LE, Rudkin GH. Staged skin and subcutaneous excision for lymphedema: a favorable report of long-term results. Plast Reconstr Surg 1998; 102:1486.</a></li><li><a class="nounderline abstract_t">Dumanian GA, Futrell JW. Radical excision and delayed reconstruction of a lymphedematous leg with a 15 year follow-up. Lymphology 1996; 29:20.</a></li><li><a class="nounderline abstract_t">Sistrunk WE. CONTRIBUTION TO PLASTIC SURGERY: REMOVAL OF SCARS BY STAGES; AN OPEN OPERATION FOR EXTENSIVE LACERATION OF THE ANAL SPHINCTER; THE KONDOLEON OPERATION FOR ELEPHANTIASIS. Ann Surg 1927; 85:185.</a></li><li><a class="nounderline abstract_t">Thompson N. The surgical treatment of chronic lymphoedema of the extremities. Surg Clin North Am 1967; 47:445.</a></li><li><a class="nounderline abstract_t">Doscher ME, Herman S, Garfein ES. Surgical management of inoperable lymphedema: the re-emergence of abandoned techniques. J Am Coll Surg 2012; 215:278.</a></li><li><a class="nounderline abstract_t">Boyages J, Kastanias K, Koelmeyer LA, et al. Liposuction for Advanced Lymphedema: A Multidisciplinary Approach for Complete Reduction of Arm and Leg Swelling. Ann Surg Oncol 2015; 22 Suppl 3:S1263.</a></li><li><a class="nounderline abstract_t">Brorson H, Ohlin K, Olsson G, et al. Controlled compression and liposuction treatment for lower extremity lymphedema. Lymphology 2008; 41:52.</a></li><li><a class="nounderline abstract_t">Eryilmaz T, Kaya B, Ozmen S, Kandal S. Suction-assisted lipectomy for treatment of lower-extremity lymphedema. Aesthetic Plast Surg 2009; 33:671.</a></li><li><a class="nounderline abstract_t">Greene AK, Slavin SA, Borud L. Treatment of lower extremity lymphedema with suction-assisted lipectomy. Plast Reconstr Surg 2006; 118:118e.</a></li><li><a class="nounderline abstract_t">Sando WC, Nahai F. Suction lipectomy in the management of limb lymphedema. Clin Plast Surg 1989; 16:369.</a></li><li><a class="nounderline abstract_t">Greene AK, Voss SD, Maclellan RA. Liposuction for Swelling in Patients with Lymphedema. N Engl J Med 2017; 377:1788.</a></li><li><a class="nounderline abstract_t">Lamprou DA, Voesten HG, Damstra RJ, Wikkeling OR. Circumferential suction-assisted lipectomy in the treatment of primary and secondary end-stage lymphoedema of the leg. Br J Surg 2017; 104:84.</a></li><li><a class="nounderline abstract_t">Brorson H. Complete Reduction of Arm Lymphedema Following Breast Cancer - A Prospective Twenty-One Years' Study. Plast Reconstr Surg 2015; 136:134.</a></li><li><a class="nounderline abstract_t">Hoffner M, Bagheri S, Hansson E, et al. SF-36 Shows Increased Quality of Life Following Complete Reduction of Postmastectomy Lymphedema with Liposuction. Lymphat Res Biol 2017; 15:87.</a></li><li><a class="nounderline abstract_t">Brorson H, Ohlin K, Olsson G, Karlsson MK. Breast cancer-related chronic arm lymphedema is associated with excess adipose and muscle tissue. Lymphat Res Biol 2009; 7:3.</a></li><li><a class="nounderline abstract_t">Brorson H, Svensson H. Liposuction combined with controlled compression therapy reduces arm lymphedema more effectively than controlled compression therapy alone. Plast Reconstr Surg 1998; 102:1058.</a></li><li><a class="nounderline abstract_t">Brorson H. Liposuction in arm lymphedema treatment. Scand J Surg 2003; 92:287.</a></li><li><a class="nounderline abstract_t">Brorson H. Liposuction gives complete reduction of chronic large arm lymphedema after breast cancer. Acta Oncol 2000; 39:407.</a></li><li><a class="nounderline abstract_t">Damstra RJ, Voesten HG, Klinkert P, Brorson H. Circumferential suction-assisted lipectomy for lymphoedema after surgery for breast cancer. Br J Surg 2009; 96:859.</a></li><li><a class="nounderline abstract_t">Qi F, Gu J, Shi Y, Yang Y. Treatment of upper limb lymphedema with combination of liposuction, myocutaneous flap transfer, and lymph-fascia grafting: a preliminary study. Microsurgery 2009; 29:29.</a></li><li><a class="nounderline abstract_t">Classen DA, Irvine L. Free muscle flap transfer as a lymphatic bridge for upper extremity lymphedema. J Reconstr Microsurg 2005; 21:93.</a></li><li><a class="nounderline abstract_t">Brazio PS, Nguyen DH. Combined Liposuction and Physiologic Treatment Achieves Durable Limb Volume Normalization in Class II-III Lymphedema: A Treatment Algorithm to Optimize Outcomes. Ann Plast Surg 2021; 86:S384.</a></li><li><a class="nounderline abstract_t">Di Taranto G, Bolletta A, Chen SH, et al. A prospective study on combined lymphedema surgery: Gastroepiploic vascularized lymph nodes transfer and lymphaticovenous anastomosis followed by suction lipectomy. Microsurgery 2021; 41:34.</a></li><li><a class="nounderline abstract_t">Miller TA. Charles procedure for lymphedema: a warning. Am J Surg 1980; 139:290.</a></li><li><a class="nounderline abstract_t">Ross JH, Kay R, Yetman RJ, Angermeier K. Primary lymphedema of the genitalia in children and adolescents. J Urol 1998; 160:1485.</a></li><li><a class="nounderline abstract_t">Dandapat MC, Mohapatro SK, Patro SK. Elephantiasis of the penis and scrotum. A review of 350 cases. Am J Surg 1985; 149:686.</a></li><li class="breakAll">Smithers CJ, Fishman SJ. Vascular anomalies. Lymphatic malformations. In: Ashcraft's Pediatric Surgery, 5th, Holcomb GW III, Murphy JP, Ostlie DJ (Eds), Saunders Elsevier, Philadelphia 2010. p.989.</li><li><a class="nounderline abstract_t">Hoffmann JN, Fertmann JP, Baumeister RG, et al. Tumescent and dry liposuction of lower extremities: differences in lymph vessel injury. Plast Reconstr Surg 2004; 113:718.</a></li><li><a class="nounderline abstract_t">Frick A, Hoffmann JN, Baumeister RG, Putz R. Liposuction technique and lymphatic lesions in lower legs: anatomic study to reduce risks. Plast Reconstr Surg 1999; 103:1868.</a></li><li><a class="nounderline abstract_t">Brorson H, Svensson H, Norrgren K, Thorsson O. Liposuction reduces arm lymphedema without significantly altering the already impaired lymph transport. Lymphology 1998; 31:156.</a></li><li><a class="nounderline abstract_t">O'Brien BM, Khazanchi RK, Kumar PA, et al. Liposuction in the treatment of lymphoedema; a preliminary report. Br J Plast Surg 1989; 42:530.</a></li></ol></div><div id="topicVersionRevision">Topic 16401 Version 26.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19001331" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17319631" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16630098" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Assessment of health-related quality of life in patients with lymphedema of the lower limb.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12413312" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Lymphedema and quality of life in survivors of early-stage breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7834431" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Post-treatment sarcoma in breast cancer patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7834431" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Post-treatment sarcoma in breast cancer patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20013596" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Comparison of primary and secondary lower-extremity lymphedema treated with supermicrosurgical lymphaticovenous anastomosis and lymphaticovenous implantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19174259" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Compression therapy and liposuction of lower legs for bilateral hereditary primary lymphedema praecox.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19461283" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Modified Charles procedure using negative pressure dressings for primary lymphedema: a functional assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19847880" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Quality of life after surgical reduction for severe primary lymphoedema of the limbs and genitalia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20555004" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Milroy's primary congenital lymphedema in a male infant and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20924350" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Diagnosis and treatment of primary lymphedema. Consensus document of the International Union of Phlebology (IUP)-2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20975845" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Primary lower limb lymphedema: a focus on its functional, social and emotional impact.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12578410" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Differential diagnosis, investigation, and current treatment of lower limb lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21124127" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Overview of surgical treatments for breast cancer-related lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9874405" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Overview of treatment options and review of the current role and use of compression garments, intermittent pumps, and exercise in the management of lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21362206" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Generalised lymphangiomatosis in an 8-year-old girl who presented with cardiomegaly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18270813" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Lymphatic venous anastomosis (LVA) for treatment of secondary arm lymphedema. A prospective study of 11 LVA procedures in 10 patients with breast cancer related lymphedema and a critical review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16444753" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Lymphatic microsurgery for the treatment of lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16445334" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Reliability and validity of arm volume measurements for assessment of lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23157502" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Standardised measurements used to order compression garments can be used to calculate arm volumes to evaluate lymphoedema treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12444879" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Upper-extremity volume measurements in women with lymphedema: a comparison of measurements obtained via water displacement with geometrically determined volume.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9215977" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Validation of an optoelectronic limb volumeter (Perometer).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19725269" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The diagnosis and treatment of peripheral lymphedema. 2009 Concensus Document of the International Society of Lymphology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19499762" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Prospective evaluation of a prevention protocol for lymphedema following surgery for breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20235160" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Microsurgery for lymphedema: clinical research and long-term results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20811210" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Lymphaticovenular bypass for lymphedema management in breast cancer patients: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33766726" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Outcomes of Vascularized Lymph Node Transplantation for Treatment of Lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35837897" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : A Prospective Study on the Safety and Efficacy of Vascularized Lymph Node Transplant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33761519" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Surgical Treatment of Lymphedema: A Systematic Review and Meta-Analysis of Controlled Trials. Results of a Consensus Conference.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11921075" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Lymphedema and microsurgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19399890" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Supermicrosurgical lymphaticovenular anastomosis and lymphaticovenous implantation for treatment of unilateral lower extremity lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19139964" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21369739" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Surgical prevention of arm lymphedema after breast cancer treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33620920" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Evaluating the Impact of Immediate Lymphatic Reconstruction for the Surgical Prevention of Lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31850991" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Is Immediate Lymphatic Reconstruction Cost-effective?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37026036" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Surgical Lymphedema Treatment: A Meta-Analysis and Recommendations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2315396" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Long-term results after microlymphaticovenous anastomoses for the treatment of obstructive lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3367429" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Microsurgical lymphovenous anastomosis for treatment of lymphedema: a critical review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10993089" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Supermicrosurgical lymphaticovenular anastomosis for the treatment of lymphedema in the upper extremities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26895326" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : A randomized control study of treating secondary stage II breast cancer-related lymphoedema with free lymph node transfer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19337095" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Vascularized groin lymph node transfer using the wrist as a recipient site for management of postmastectomy upper extremity lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16495693" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29518822" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Double vascularized omentum lymphatic transplant (VOLT) for the treatment of lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27425000" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Free vascularized lymph node transfer for treatment of lymphedema: A systematic evidence based review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27439587" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Long-term outcomes of the minimally invasive free vascularized omental lymphatic flap for the treatment of lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3376519" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : The complete amino acid sequences of the B800-850 antenna polypeptides from Rhodopseudomonas acidophila strain 7750.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32889875" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Outcomes for Physiologic Microsurgical Treatment of Secondary Lymphedema Involving the Extremity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24165613" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12616515" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Follow-up study of upper limb lymphedema patients treated by microsurgical lymphaticovenous implantation (MLVI) combined with compression therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24352208" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Operative treatment of peripheral lymphedema: a systematic meta-analysis of the efficacy and safety of lymphovenous microsurgery and tissue transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2817711" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Role of tensor fascia lata musculocutaneous flap in lymphedema of the lower extremity and external genitalia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21129845" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Assessment and follow-up of patency after lymphovenous microsurgery for treatment of secondary lymphedema in external male genital organs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3563896" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Surgical treatment of lymphedema: a report on 652 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3563896" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Surgical treatment of lymphedema: a report on 652 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1099339" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Comments on operations for lower limb lymphoedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9774002" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Staged skin and subcutaneous excision for lymphedema: a favorable report of long-term results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8721975" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Radical excision and delayed reconstruction of a lymphedematous leg with a 15 year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17865614" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : CONTRIBUTION TO PLASTIC SURGERY: REMOVAL OF SCARS BY STAGES; AN OPEN OPERATION FOR EXTENSIVE LACERATION OF THE ANAL SPHINCTER; THE KONDOLEON OPERATION FOR ELEPHANTIASIS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6022236" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : The surgical treatment of chronic lymphoedema of the extremities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22560317" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Surgical management of inoperable lymphedema: the re-emergence of abandoned techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26122375" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Liposuction for Advanced Lymphedema: A Multidisciplinary Approach for Complete Reduction of Arm and Leg Swelling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18720912" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Controlled compression and liposuction treatment for lower extremity lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19434444" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Suction-assisted lipectomy for treatment of lower-extremity lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17016168" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Treatment of lower extremity lymphedema with suction-assisted lipectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2736873" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Suction lipectomy in the management of limb lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29091562" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Liposuction for Swelling in Patients with Lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27809337" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Circumferential suction-assisted lipectomy in the treatment of primary and secondary end-stage lymphoedema of the leg.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26397660" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Complete Reduction of Arm Lymphedema Following Breast Cancer - A Prospective Twenty-One Years' Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28135120" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : SF-36 Shows Increased Quality of Life Following Complete Reduction of Postmastectomy Lymphedema with Liposuction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19231988" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Breast cancer-related chronic arm lymphedema is associated with excess adipose and muscle tissue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9734424" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Liposuction combined with controlled compression therapy reduces arm lymphedema more effectively than controlled compression therapy alone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14758919" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Liposuction in arm lymphedema treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10987239" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Liposuction gives complete reduction of chronic large arm lymphedema after breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19591161" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Circumferential suction-assisted lipectomy for lymphoedema after surgery for breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18942656" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Treatment of upper limb lymphedema with combination of liposuction, myocutaneous flap transfer, and lymph-fascia grafting: a preliminary study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15739144" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Free muscle flap transfer as a lymphatic bridge for upper extremity lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33976067" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Combined Liposuction and Physiologic Treatment Achieves Durable Limb Volume Normalization in Class II-III Lymphedema: A Treatment Algorithm to Optimize Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32845534" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : A prospective study on combined lymphedema surgery: Gastroepiploic vascularized lymph nodes transfer and lymphaticovenous anastomosis followed by suction lipectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6986805" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Charles procedure for lymphedema: a warning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9751400" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Primary lymphedema of the genitalia in children and adolescents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3993854" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Elephantiasis of the penis and scrotum. A review of 350 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3993854" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Elephantiasis of the penis and scrotum. A review of 350 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14758241" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Tumescent and dry liposuction of lower extremities: differences in lymph vessel injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10359247" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Liposuction technique and lymphatic lesions in lower legs: anatomic study to reduce risks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9949387" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Liposuction reduces arm lymphedema without significantly altering the already impaired lymph transport.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2804517" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Liposuction in the treatment of lymphoedema; a preliminary report.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
